The Benefits of Psychedelic Drug Application for Clinical Treatment of Mental Illness
View/ Open
Issue Date
2013-08-01Author
Shumate, Timothy
Format
8 pages
Type
Article
Metadata
Show full item recordAbstract
The use of psychedelic drugs, such as lysergic acid diethylamide (LSD), 3,4- methylenedioxymethamphetamine (MDMA), and 4-phosphoryloxy- N,N -dimethyltryptamine (psilocybin), in the clinical treatment of mental health disorders has sparked a broad spectrum ethical debate amongst both the medical field and the general public. This is due to the negative connotations of the drugs being illegal and that they are used by subpopulations of our society for recreational use. The purpose of this paper is to discuss the positive implications of the use of the psychedelic drugs towards mental well-being of patients and explore the role of a nurse in its clinical application.
Description
About the author: Tim Shumate is from Wichita, Kansas. He was the recipient of the John F. and Ella Hull Scholarship while a student. He is starting his career in the Wichita area in an acute care setting. In his future he sees himself becoming involved in nursing leadership and management then eventually returning to school for a Doctorate of Nursing Practice with specialization in Family Medicine. He thanks his wife Lindsay for all the time she spent editing and discussing his papers and for her continued support throughout his journey of becoming a nurse. He also credits the School of Nursing at KU for providing one of the best experiences of his life.
Collections
- Volume 6, Issue 1 [11]
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.